Insider · CIK 0001465994
Jennifer Lew
Files at ANNX (Annexon, Inc.), BOLD (Boundless Bio, Inc.). First filing Feb 18, 2025, latest Mar 4, 2026.
In brief
Jennifer Lew files SEC Form 4 as CFO and director at ANNX (Annexon, Inc.), and also at BOLD (Boundless Bio, Inc.). Since Feb 18, 2025, Jennifer Lew has reported 0 open-market buys worth $0 and 5 open-market sells worth $99k, the latest filed on Mar 4, 2026.
A track record needs three past buys with six months of prices behind them; Jennifer Lew has 0, so none is measured yet.
The newest scored trade: sold $30k of ANNX on Mar 2, 2026, filed Mar 4, 2026, scored 42 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $70k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANNX: Annexon, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Annexon, Inc. | $30k 5,565 shares | -3% | +300% from low-21% from high | |
| 43Moderate | Annexon, Inc. | $40k 7,851 shares | -6% | +267% from low-27% from high | |
| 37Weak | Annexon, Inc. | $2,882 1,117 shares | -1% | +89% from low-66% from high | |
| 37Weak | Annexon, Inc. | $20k 6,912 shares | -8% | 0% from low-65% from high | |
| 37Weak | Annexon, Inc. | $5,322 1,786 shares | -2% | +0% from low-61% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 2, 2026 | ANNX Annexon, Inc. | 5,565 0.00% of outstanding | $30k | Mar 2, 2026 | $40k |
| Feb 18, 2026 | ANNX Annexon, Inc. | 7,851 0.01% of outstanding | $40k | Feb 18, 2026 | none |
| Jul 14, 2025 | ANNX Annexon, Inc. | 1,117 0.00% of outstanding | $2,881 | Jul 14, 2025 | none |
| Feb 18, 2025 | ANNX Annexon, Inc. | 8,338 0.01% of outstanding | $24k | Feb 18, 2025 | $5,314 |
| Feb 13, 2025 | ANNX Annexon, Inc. | 1,786 0.00% of outstanding | $5,314 | Feb 13, 2025 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | BOLD Boundless Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +32,000 | $0.00 | $0 | 32,000 | Jun 15, 2026 |
| Mar 2, 2026 | ANNX Annexon, Inc. | SOpen-market sale Common Stock | -5,565 | $5.42 | $30k | 170,700 | Mar 4, 2026 |
| Feb 19, 2026 | ANNX Annexon, Inc. | AGrant or award Common Stock | +62,500 | $0.00 | $0 | 176,265 | Feb 23, 2026 |
| Feb 19, 2026 | ANNX Annexon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +250,000 | $0.00 | $0 | 250,000 | Feb 23, 2026 |
| Feb 18, 2026 | ANNX Annexon, Inc. | SOpen-market sale Common Stock | -7,851 | $5.11 | $40k | 113,765 | Feb 20, 2026 |
| Jul 14, 2025 | ANNX Annexon, Inc. | SOpen-market sale Common Stock | -1,117 | $2.58 | $2,882 | 121,616 | Jul 16, 2025 |
| Jun 23, 2025 | BOLD Boundless Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +16,000 | $0.00 | $0 | 16,000 | Jun 23, 2025 |
| Feb 27, 2024 | ANNX Annexon, Inc. | AGrant or award Common Stock | +44,963 | $0.00 | $0 | 122,733 | Mar 3, 2025 |
| Feb 27, 2025 | ANNX Annexon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +272,575 | $0.00 | $0 | 272,575 | Mar 3, 2025 |
| Feb 18, 2025 | ANNX Annexon, Inc. | SOpen-market sale Common Stock | -6,912 | $2.92 | $20k | 77,770 | Feb 20, 2025 |
| Feb 13, 2025 | ANNX Annexon, Inc. | SOpen-market sale Common Stock | -1,786 | $2.98 | $5,322 | 84,682 | Feb 18, 2025 |
Questions about Jennifer Lew
Answered from the filings on this page, as of the latest one.
Is Jennifer Lew buying or selling?
In the last 12 months Jennifer Lew reported 0 open-market buys worth $0 and 2 open-market sells worth $70k on SEC Form 4; the latest was sold $30k of ANNX on Mar 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Jennifer Lew's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jennifer Lew has 0.
Where does Jennifer Lew file Form 4?
Jennifer Lew has filed Form 4 at ANNX (Annexon, Inc.) as EVP & CHIEF FINANCIAL OFFICER; BOLD (Boundless Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.